For this purpose, we sequenced the complete coding and flanking regulatory regions of PALB2 from constitutional DNA of 152 patients with hereditary predisposition to breast cancer, all previously employed to study the distribution of germline mutations in BRCA1, BRCA2 [12, 13]. This evidence concerns the gene BRCA2 and breast cancer.